BMC Complementary Medicine and Therapies (May 2022)

Wild Egyptian medicinal plants show in vitro and in vivo cytotoxicity and antimalarial activities

  • Ahmed M. Abdou,
  • Abdel-latif S. Seddek,
  • Noha Abdelmageed,
  • Mohamed O. Badry,
  • Yoshifumi Nishikawa

DOI
https://doi.org/10.1186/s12906-022-03566-5
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background Medicinal plants have been successfully used as an alternative source of drugs for the treatment of microbial diseases. Finding a novel treatment for malaria is still challenging, and various extracts from different wild desert plants have been reported to have multiple medicinal uses for human public health, this study evaluated the antimalarial efficacy of several Egyptian plant extracts. Methods We assessed the cytotoxic potential of 13 plant extracts and their abilities to inhibit the in vitro growth of Plasmodium falciparum (3D7), and to treat infection with non-lethal Plasmodium yoelii 17XNL in an in vivo malaria model in BALB/c mice. Results In vitro screening identified four promising candidates, Trichodesma africanum, Artemisia judaica, Cleome droserifolia, and Vachellia tortilis, with weak-to-moderate activity against P. falciparum erythrocytic blood stages with mean half-maximal inhibitory concentration 50 (IC50) of 11.7 μg/ml, 20.0 μg/ml, 32.1 μg/ml, and 40.0 μg/ml, respectively. Their selectivity index values were 35.2, 15.8, 11.5, and 13.8, respectively. Among these four candidates, T. africanum crude extract exhibited the highest parasite suppression in a murine malaria model against P. yoelii. Conclusion Our study identified novel natural antimalarial agents of plant origin that have potential for development into therapeutics for treating malaria.

Keywords